References |
Kolterman, O. G., Kim, D. D., Shen L., Ruggles J. A., Nielsen L. L., Fineman M. S., Baron A. D. (2005) Pharmacokinetics, pharmacodynamics, and safety of exenatide in patients with type 2 diabetes mellitus. Am J Health Syst Pharm 62: 173–181. PMID: 15700891
Liao, S., Liang, Y., Zhang, Z., Li, J., Wang, J., Wang, X., Dou, G., Zhang, Z. and Liu, K. (2015). In Vitro Metabolic Stability of Exendin-4: Pharmacokinetics and Identification of Cleavage Products. PLOS ONE, 10(2), e0116805.
Luciani, P., Deledda, C., Benvenuti, S., Squecco, R., Cellai, I., Fibbi, B., Marone, I., Giuliani, C., Modi, G., Francini, F., Vannelli, G. and Peri, A. (2013). Exendin-4 Induces Cell Adhesion and Differentiation and Counteracts the Invasive Potential of Human Neuroblastoma Cells. PLoS ONE, 8(8), e71716. PMID: 23990978 |